Feed Top Reports Pricing

⌘K

14:48:17·570d

SECFiling

SEC Form 10-K filed by Renalytix plc

RNLX· Renalytix plc

Health Care

Full content unavailable. See the original source below.

Original source

Companies

RNLX
Renalytix plc
Health Care

Recent analyst ratings

Jan 18UpdateHC Wainwright & Co.$30.00
Jan 4UpdateBTIG$24.00
Oct 4UpdateGuggenheim$28.00
Jul 2UpdateBerenberg$38.00

Related

SEC559d
SEC Form DEF 14A filed by Renalytix plc
PR562d
Commencement of trading on OTCQB in the United States
13D/G568d
Amendment: SEC Form SC 13D/A filed by Renalytix plc
SEC569d
SEC Form PRE 14A filed by Renalytix plc
SEC569d
Renalytix plc filed SEC Form 8-K: Results of Operations and Financial Condition, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities
SEC604d
Renalytix plc filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits
SEC647d
Renalytix plc filed SEC Form 8-K: Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits
NEWS650d
HC Wainwright & Co. Reiterates Buy on Renalytix, Maintains $3 Price Target

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds

Top lists

Trending By market cap Active companies Analyst upgrades Insider purchases FDA approvals SEC filings Sectors Market reports

Company

About Pricing Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022